By Admin at 27 Apr 2017

New research is helping to make liquid biopsies a readily available alternative to invasive biopsies for cancer patients. Traditional tissue biopsies have historically been necessary to make definitive cancer diagnoses, but such procedures are invasive, costly and carry risks to the patient.

By Admin at 26 Oct 2015

Health organizations have long recommended that men begin yearly PSA screening at the age of 50, or even at 40 or 45 if a high risk of prostate cancer was present. This is now controversial, however, in large part because many benign prostate conditions can also cause PSA levels to rise.

By Admin at 19 Oct 2015

Research published in the Journal of Clinical Oncology, revealed 20 genes, or biomarkers, that are associated with prostate cancer. Some of them were also associated with a particularly aggressive form of the disease.

By Admin at 11 Sep 2015

Some health organizations have begun to recommend against routine PSA screening, because it may detect tumors that won’t pose any risk, subjecting men to unnecessary treatment and stress.